Publications

20 May

Statement on Conflicts of Interests delivered at WHA

18 March

Statement on EU India and EU Mercosur Free-Trade Negotiations

21 January

Medicines pay-for-delay back under the microscope

1 January

Transparency of European Medicines Regulation

29 November

Increasing Calls Within the EU for New Models of Medical Innovation

18 October

EMA Talks the ‘Conflicts of Interest’ Talk, but Will it Walk the Walk?

30 September

EU Citizens Get a Voice in Pharmacovigilance

1 July

Как распознавать продвижение лекарств и как к нему относиться: Практическое руководство

1 July

Comprender la promoción farmacéutica y responder a ella: Una guía práctica

1 July

Understanding & Responding to Pharmaceutical Promotion: A Practical Guide

11 May

WHO Should Refocus its Efforts on Wider Public Health Threats

6 May

Direct Patient Reporting of Adverse Drug Reactions

23 March

HAI Europe is Granted Full Membership by the European Medicines Agency

30 November

European Medicines’ Policy Where it Belongs

22 November

Unbiased medicines’ information: European best practices

1 November

Wyzwanie dla niezależnej informacji: dyrektywa w sprawie informowania pacjentów

1 October

Rozumienie promocji leków i reagowanie na nia: Praktyczny przewodnik 2009

1 October

Understanding and Responding to Pharmaceutical Promotion: A Practical Guide

11 August

The Tide is Turning Against Pharmaceutical Ads

11 August

Protect Legitimate Trade in Essential Medicines

10 August

DG Competition Pharmaceutical Sector Inquiry – Final Report

3 April

HAI Requests Government Documents on Generic Medicines Seizures

20 March

Release of Generic ARV Medicines by Dutch Customs Authorities

27 July

HAI Statutenwijziging (HAI Constitution – Dutch)

27 July

HAI Constitution

7 October

Fast, Furious, and Flexible

3 March

East Africa Community and a 10% Tax on Medicines